IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 46 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,942,926 | +232.1% | 249,382 | +283.7% | 0.01% | +250.0% |
| Q2 2023 | $3,897,400 | +43070.1% | 65,000 | -64.4% | 0.00% | -60.0% |
| Q1 2023 | $9,028 | -60.0% | 182,603 | -53.9% | 0.01% | -61.5% |
| Q4 2022 | $22,584 | -99.7% | 395,728 | +153.4% | 0.01% | +225.0% |
| Q3 2022 | $7,331,000 | +268.8% | 156,182 | +193.1% | 0.00% | +300.0% |
| Q2 2022 | $1,988,000 | +105.2% | 53,278 | +64.4% | 0.00% | 0.0% |
| Q1 2022 | $969,000 | -72.1% | 32,400 | -65.5% | 0.00% | -50.0% |
| Q3 2021 | $3,478,000 | -13.6% | 93,812 | -9.0% | 0.00% | 0.0% |
| Q2 2021 | $4,027,000 | -53.6% | 103,121 | -49.4% | 0.00% | -66.7% |
| Q1 2021 | $8,670,000 | – | 203,655 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $24,560,000 | 4.02% |
| Rock Springs Capital Management LP | 2,292,285 | $97,583,000 | 2.13% |
| RTW INVESTMENTS, LP | 1,245,532 | $50,142,000 | 0.78% |
| Avidity Partners Management LP | 550,000 | $23,414,000 | 0.65% |
| Samsara BioCapital, LLC | 80,000 | $3,406,000 | 0.63% |
| Bain Capital Public Equity Management II, LLC | 300,871 | $12,808,000 | 0.53% |
| GENERAL ATLANTIC, L.P. | 950,000 | $40,442,000 | 0.47% |
| Baker Brothers Advisors | 2,520,730 | $107,307,000 | 0.46% |
| Perceptive Advisors | 400,000 | $17,028,000 | 0.22% |
| Pinz Capital Management, LP | 18,700 | $796,000 | 0.21% |